UBS Group Issues Pessimistic Forecast for Cross Country Healthcare (NASDAQ:CCRN) Stock Price

Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) had its price objective decreased by investment analysts at UBS Group from $18.61 to $16.50 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the business services provider’s stock. UBS Group’s price objective points to a potential upside of 17.94% from […]

Leave a Reply

Your email address will not be published.

Previous post Citigroup Cuts Confluent (NASDAQ:CFLT) Price Target to $25.00
Next post Citigroup Forecasts Strong Price Appreciation for Maplebear (NASDAQ:CART) Stock